Rankings
▼
Calendar
CRMD Q4 2016 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$121,715
+430.4% YoY
Gross Profit
$36,384
29.9% margin
Operating Income
-$6M
-5282.3% margin
Net Income
-$6M
-5257.7% margin
EPS (Diluted)
$-0.79
QoQ Revenue Growth
+173.8%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$414,293
Balance Sheet
Total Assets
$22M
Total Liabilities
$4M
Stockholders' Equity
$18M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$121,715
$22,946
+430.4%
Gross Profit
$36,384
-$141,258
+125.8%
Operating Income
-$6M
-$2M
-178.3%
Net Income
-$6M
-$4M
-65.5%
← FY 2016
All Quarters
Q1 2017 →